JPMorgan Chase & Co. Reiterates “Underweight” Rating for Clorox (NYSE:CLX)

Clorox (NYSE:CLXGet Free Report)‘s stock had its “underweight” rating restated by equities research analysts at JPMorgan Chase & Co. in a research report issued on Friday, Marketbeat reports. They presently have a $99.00 target price on the stock, down from their prior target price of $117.00. JPMorgan Chase & Co.‘s price target indicates a potential downside of 5.31% from the company’s previous close.

Other research analysts have also recently issued reports about the stock. Evercore lowered their target price on shares of Clorox from $132.00 to $115.00 and set an “underperform” rating on the stock in a report on Wednesday, February 4th. UBS Group reduced their price target on shares of Clorox from $121.00 to $110.00 and set a “neutral” rating on the stock in a research report on Tuesday, April 7th. Wells Fargo & Company reduced their price target on shares of Clorox from $125.00 to $110.00 and set an “equal weight” rating on the stock in a research report on Wednesday, April 8th. Rothschild & Co Redburn set a $117.00 price target on shares of Clorox in a research report on Friday, February 13th. Finally, Royal Bank Of Canada reduced their price target on shares of Clorox from $132.00 to $127.00 and set a “sector perform” rating on the stock in a research report on Thursday, April 9th. One equities research analyst has rated the stock with a Buy rating, twelve have assigned a Hold rating and four have given a Sell rating to the company. Based on data from MarketBeat.com, the company currently has a consensus rating of “Reduce” and an average target price of $113.93.

Read Our Latest Analysis on CLX

Clorox Stock Up 2.1%

Shares of CLX opened at $104.56 on Friday. Clorox has a 12 month low of $96.66 and a 12 month high of $143.96. The firm’s 50 day moving average is $112.85 and its 200-day moving average is $110.19. The stock has a market capitalization of $12.64 billion, a PE ratio of 17.08, a P/E/G ratio of 0.51 and a beta of 0.65. The company has a current ratio of 0.74, a quick ratio of 0.48 and a debt-to-equity ratio of 71.03.

Clorox (NYSE:CLXGet Free Report) last announced its earnings results on Tuesday, February 3rd. The company reported $1.39 EPS for the quarter, missing the consensus estimate of $1.43 by ($0.04). Clorox had a return on equity of 383.01% and a net margin of 11.17%.The business had revenue of $1.67 billion for the quarter, compared to the consensus estimate of $1.64 billion. During the same period in the prior year, the business posted $1.55 earnings per share. The firm’s revenue for the quarter was down .8% compared to the same quarter last year. Equities research analysts forecast that Clorox will post 7.15 EPS for the current year.

Institutional Trading of Clorox

Several large investors have recently made changes to their positions in CLX. CENTRAL TRUST Co boosted its position in Clorox by 3.4% in the first quarter. CENTRAL TRUST Co now owns 14,253 shares of the company’s stock valued at $1,477,000 after buying an additional 467 shares in the last quarter. Webster Bank N. A. boosted its position in Clorox by 61.2% in the first quarter. Webster Bank N. A. now owns 395 shares of the company’s stock valued at $41,000 after buying an additional 150 shares in the last quarter. Evolve Private Wealth LLC boosted its position in Clorox by 69.2% in the first quarter. Evolve Private Wealth LLC now owns 4,843 shares of the company’s stock valued at $502,000 after buying an additional 1,981 shares in the last quarter. Scott & Selber Inc. boosted its position in Clorox by 47.2% in the first quarter. Scott & Selber Inc. now owns 24,839 shares of the company’s stock valued at $2,574,000 after buying an additional 7,964 shares in the last quarter. Finally, First Community Trust NA boosted its position in Clorox by 5.6% in the first quarter. First Community Trust NA now owns 10,074 shares of the company’s stock valued at $1,044,000 after buying an additional 533 shares in the last quarter. Institutional investors and hedge funds own 78.53% of the company’s stock.

About Clorox

(Get Free Report)

The Clorox Company is a leading manufacturer and marketer of consumer and professional products designed to help people care for their homes and live healthy, sustainable lives. Its portfolio spans cleaning and household products, food and beverages, water filtration systems and cat litter, serving both retail and institutional customers. The company’s flagship bleach and disinfecting products are well known in the United States and many international markets, where they help prevent the spread of germs in homes, hospitals, schools and businesses.

Clorox’s diverse brand lineup includes liquid bleach and surface cleaners, eco-friendly cleaning tools, food preservation and preparation items, charcoal grills and briquettes, specialty foods and beverages, pet care products and personal care lines.

See Also

Analyst Recommendations for Clorox (NYSE:CLX)

Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.